Home PrintSearch
Resize Text
European Financial Services Round Table
 

Sir Tom McKillop
Chairman
The Royal Bank of Scotland Group

Tom McKillop was born in Ayrshire, Scotland in 1943 and educated at Irvine Royal Academy and Glasgow University (BSc Hons and PhD in Chemistry). He joined ICI's Corporate Research Laboratory at Runcorn in 1969 after post-doctoral research work in Paris, his early research interests ranging from synthetic chemistry to quantum mechanics and molecular biology.

He moved to ICI Pharmaceuticals Division in 1975 and held a number of positions in Research, including Director of Research for ICI's Pharmaceutical Business in France, before being appointed General Manager (Research) and then General Manager (Development). In 1989 he was appointed Technical Director of ICI Pharmaceuticals, a role in which he had international responsibility for Research, Development and Production.

In 1994, he was appointed Chief Executive Officer of Zeneca Pharmaceuticals   Zeneca having demerged from ICI in 1993   and, on completion of the merger of Astra and Zeneca in April 1999, he became Chief Executive of AstraZeneca PLC, a position he held until retiring on 31 December 2005. His wider industry activities included periods as Chairman of the British Pharma Group, President of the European Federation of Pharmaceutical Industries and Associations, Chairman of the Pharmaceutical Industry Task Force, and as a member of The European Round Table of Industrialists.

In September 2005 he was appointed Deputy Chairman of The Royal Bank of Scotland and in April 2006 he succeeded to the chairmanship of the group. The Royal Bank of Scotland is one of the world’s largest banking and financial services groups with over £750 billion in total assets and more than 140,000 employees engaged in retail and corporate banking as well as insurance, wealth management and other financial services.

Currently Sir Tom is also a non-executive director of BP plc, Pro-Chancellor of Leicester University, a Trustee of the Council for Industry and Higher Education, and a Trustee of The Darwin Trust of Edinburgh.

During his career Sir Tom has received many scholarly awards and fellowships. He is a Fellow of The Royal Society, a Fellow of The Royal Society of Edinburgh, a Fellow of The Academy of Medical Sciences, an Honorary Fellow of The Royal Society of Chemistry, an Honorary Fellow of The Institute of Chemical Engineers, and a Companion of The Institute of Management. He has also been granted numerous honorary degrees from British Universities and in 2002 he received a knighthood for his services to the Pharmaceutical industry.

Sir Tom is married with three children and several grandchildren. His interests include sport, reading and music.